• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DarioHealth inks U.S. distro deal for digital diabetes management program

January 2, 2019 By Sarah Faulkner

DarioHealth updatedDarioHealth (NSDQ:DRIO) said today that it inked a deal with healthcare products provider Better Living Now for the distribution of its blood glucose monitoring system and the DarioEngage digital health program.

According to the terms of the deal, BLN plans to buy DarioHealth’s smart glucose meter and test strips to distribute to its customers. The agreement also enables BLN to provide diabetes management coaching to its customers through the DarioEngage platform on a monthly subscription basis.

BLN’s customers consist of managed care plans in the U.S., Puerto Rico and the U.S. Virgin Islands, according to DarioHealth.

“We are very pleased to partner with BLN to make DarioHealth products and services readily available to more people across the U.S., through their robust contracted insurance networks,” CEO Erez Raphael said in prepared remarks. “Through this distribution agreement, we believe that Dario will become a standard product offered by many managed care plans across the U.S., thereby potentially and significantly increasing our market penetration.”

“BLN is committed to providing the best and most comprehensive diabetes management program. The DarioHealth platform increases the opportunity for users to self-manage through the Dario app and the DarioEngage coaching platform. We believe it will improve clinical outcomes for users while creating improved economics for managed care plans,” BLN’s president & CEO Daniel Pope added.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, mHealth (Mobile Health), Wall Street Beat Tagged With: dariohealth

IN CASE YOU MISSED IT

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance
  • Rapid Dose closes first tranche of $5M financing

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS